Mansbach, Robert S.

Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry

Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Cited by 930

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology

Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Cited by 533

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist

Mansbach, R. S., Brooks, E. N., & Chen, Y. L. (1997) · European Journal of Pharmacology

Stress Responses and CortisolTreatment of Major Depression

Cited by 195

Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands

Mansbach, R. S., & Geyer, M. A. (1988) · European Journal of Pharmacology

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 86

Absorption, Distribution, and Excretion of 14C-APX001 after Single-Dose Administration to Rats and Monkeys

Mansbach, R., Shaw, K. J., Hodges, M. R., Coleman, S., & Fitzsimmons, M. E. (2017) · Open Forum Infectious Diseases

Pharmacogenetics and Drug MetabolismAntifungal resistance and susceptibility

Cited by 21